Wellstat Therapeutics Corporation (Vistogard and Xuriden) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Wellstat Therapeutics Corporation (Vistogard and Xuriden) General Information

Description

A portfolio of two medicines commercially available in the United States. The medicines are an emergency treatment for adult and pediatric patients.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
SERB Pharmaceuticals
Corporate Office
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Wellstat Therapeutics Corporation (Vistogard and Xuriden) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Wellstat Therapeutics Corporation (Vistogard and Xuriden)‘s full profile, request access.

Request a free trial

Wellstat Therapeutics Corporation (Vistogard and Xuriden) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Wellstat Therapeutics Corporation (Vistogard and Xuriden)‘s full profile, request access.

Request a free trial

Wellstat Therapeutics Corporation (Vistogard and Xuriden) FAQs

  • Where is Wellstat Therapeutics Corporation (Vistogard and Xuriden) headquartered?

    Wellstat Therapeutics Corporation (Vistogard and Xuriden) is headquartered in .

  • What industry is Wellstat Therapeutics Corporation (Vistogard and Xuriden) in?

    Wellstat Therapeutics Corporation (Vistogard and Xuriden)’s primary industry is Buildings and Property.

  • Is Wellstat Therapeutics Corporation (Vistogard and Xuriden) a private or public company?

    Wellstat Therapeutics Corporation (Vistogard and Xuriden) is a Private company.

  • What is Wellstat Therapeutics Corporation (Vistogard and Xuriden)’s current revenue?

    The current revenue for Wellstat Therapeutics Corporation (Vistogard and Xuriden) is .

  • Who are Wellstat Therapeutics Corporation (Vistogard and Xuriden)’s investors?

    Wellstat Therapeutics Corporation has invested in Wellstat Therapeutics Corporation (Vistogard and Xuriden).

  • When was Wellstat Therapeutics Corporation (Vistogard and Xuriden) acquired?

    Wellstat Therapeutics Corporation (Vistogard and Xuriden) was acquired on 13-Jul-2023.

  • Who acquired Wellstat Therapeutics Corporation (Vistogard and Xuriden)?

    Wellstat Therapeutics Corporation (Vistogard and Xuriden) was acquired by SERB Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process